F19.10

Other psychoactive substance abuse, uncomplicated

Other psychoactive substance abuse, uncomplicated, is a clinical diagnosis used for patients who demonstrate a pattern of harmful use of substances that are not classified under more common categories (such as alcohol, opioids, or cannabis) or who engage in polysubstance abuse where no single substance predominates. This category often includes the abuse of inhalants, volatile solvents, designer drugs, or synthetic compounds. The 'uncomplicated' designation signifies that at the time of the encounter, the patient is not experiencing acute intoxication, withdrawal symptoms, or any drug-induced mental disorders (such as delirium, psychosis, or mood disorders). The focus is on the behavioral and physical harm resulting from the recurrent use of these substances despite known negative consequences.

Clinical Symptoms

  • Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home
  • Recurrent substance use in situations in which it is physically hazardous (e.g., driving or operating machinery)
  • Continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance
  • Craving or a strong desire to use the 'other' psychoactive substance
  • Neglect of alternative pleasures or interests in favor of substance use
  • Use of substances such as glue, gasoline, or aerosol sprays (inhalant abuse)
  • Engagement in risky behaviors while seeking or under the influence of designer drugs
  • Evidence of physical harm (e.g., organ damage or neurological deficits) related to the specific substance consumed

Common Causes

  • Genetic predisposition and family history of substance use disorders
  • Neurochemical dysregulation in the brain's reward and dopamine pathways
  • Comorbid psychiatric conditions such as depression, anxiety, or personality disorders (self-medication)
  • Environmental factors including low socioeconomic status, lack of social support, or peer pressure
  • Early exposure to substances during critical developmental periods of the adolescent brain
  • High availability and low cost of household inhalants or unregulated synthetic compounds
  • Chronic stress and maladaptive coping mechanisms

Documentation & Coding Tips

Differentiate abuse from dependence by documenting the absence of tolerance and withdrawal symptoms.

Example: Patient presents with problematic use of synthetic cathinones. They exhibit failure to fulfill major role obligations at work but lack physiological withdrawal symptoms or increased tolerance. Diagnosed with other psychoactive substance abuse, uncomplicated. Billing Focus: Clearly state absence of dependence. Risk Adjustment: Distinguishing abuse from dependence is vital for accurate HCC mapping, as dependence codes (F19.2x) carry higher risk scores than uncomplicated abuse (F19.10).

Billing Focus: Documentation of substance type (synthetic/other) and lack of dependence.

Document the specific psychoactive substance being abused rather than using general terms when the substance does not fit other categories.

Example: Clinical Note: 24-year-old male with persistent inhalation of volatile nitrites (poppers). Usage occurs weekly and has led to hazardous social situations. No concurrent mood or psychotic disorders noted. Billing Focus: Explicitly name the substance to support the use of the other category. Risk Adjustment: Specificity prevents under-coding or the use of unspecified codes (F19.90) which may trigger audits.

Billing Focus: Substance specificity and clinical manifestations.

Explicitly state that the condition is uncomplicated by documenting the absence of intoxication, withdrawal, or substance-induced mental disorders.

Example: Evaluation: Patient demonstrates maladaptive pattern of synthetic cannabinoid use. Physical exam shows no acute intoxication. Patient denies hallucinatory experiences or withdrawal cravings. Plan: Outpatient behavioral therapy. Billing Focus: Use of the .10 suffix requires documentation of zero complications. Risk Adjustment: Complicated abuse codes (e.g., F19.121) change the severity level in risk-based models.

Billing Focus: Documentation of uncomplicated status.

Describe the impact on the patient's psychosocial environment to justify the abuse diagnosis.

Example: History: Patient reports recurring use of unknown bath salts resulting in legal issues and strained family relationships. Despite these consequences, the patient continues the pattern. No physical dependence observed. Billing Focus: Socio-occupational impairment documentation. Risk Adjustment: Supports medical necessity for higher-level E/M services and counseling.

Billing Focus: Psychosocial impact and medical necessity.

Include screening tool results (e.g., DAST-10) to provide objective evidence of the abuse pattern.

Example: Assessment: DAST-10 score of 4 indicates a moderate level of drug-related problems. Patient identifies use of multiple synthetic research chemicals. No signs of physiological dependence. Billing Focus: Standardized tool scores provide objective evidence for audit defense. Risk Adjustment: Quantitative data supports the diagnosis of abuse versus recreational use.

Billing Focus: Standardized screening tool results.

Relevant CPT Codes

Related Diagnoses

Hierarchy